Atossa Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2011 | $-3.5M | $-3.5M | — | $140.1K |
| FY2012 | $-3.9M | $-3.9M | — | $121.8K |
| FY2013 | $-8.8M | $-8.8M | — | $1.4M |
| FY2014 | $-10.6M | $-10.6M | — | $556.3K |
| FY2015 | $-14.0M | $-14.0M | — | $840.1K |
| FY2016 | $-5.4M | $-5.4M | — | — |
| FY2017 | $-6.6M | $-6.6M | — | — |
| FY2018 | $-9.0M | $-9.1M | $110.9K | — |
| FY2019 | $-9.1M | $-9.1M | $7.6K | — |
| FY2020 | $-11.6M | $-11.6M | $9.0K | — |
| FY2021 | $-16.5M | $-16.5M | $9.0K | — |
| FY2022 | $-20.8M | $-20.8M | $27.0K | $6.8M |
| FY2023 | $-20.9M | $-21.0M | $14.0K | $4.6M |
| FY2024 | $-21.0M | $-21.0M | $19.0K | $2.3M |
| FY2025 | $-29.8M | $-29.8M | $23.0K | $2.6M |